Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-128567
Filing Date
2016-06-17
Accepted
2016-06-17 16:19:13
Documents
1
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3990
  Complete submission text file 0001209191-16-128567.txt   5377
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 2 MERCER ROAD NATICK MA 01760
Business Address
Mirza Mansoor Raza (Reporting) CIK: 0001588389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 161720348